AbbVie presents hematological cancer research in Bilbao

At the LXVIII National Congress of the Spanish Society of Hematology and Hemotherapy (SEHH) held in Bilbao, AbbVie highlighted advancements in oncohematology. Scientific sessions focused on chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), and diffuse large B-cell lymphoma (DLBCL).

During the 'HematoWays' symposium, experts discussed the path toward treatment-free intervals in CLL, emphasizing the need to individualize care for elderly patients by considering personal circumstances alongside clinical needs. Additionally, specialists addressed the integration of scientific evidence and clinical experience in managing DLBCL.